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3p-Acetoxy- 5-androsteno[ 16, 17-c]-l' ,2',5' -oxadiazole N-oxide (1), 3-methoxy-1 ,3- 5(10)-estra-
trieno[ 16, 17-c]-l' ,2' ,5' -oxadiazole N-oxide (2), [16,17 -cjfuroxano- 5 a-androstano[ 3,4-c]furazan (3) and
17p-acetoxy-5a-androstano[3,4-c]-1',2',5'-oxadiazole N-oxide (4) have been synthesised to investigate
the reactions with triethyl phosphite. The products obtained have been identified. Furazan N-oxide
fused to D-ring gives dinitriles 5,6 and 7 whereas furoxan at 3,4-position yield furazan 8.
It is well known that amine oxides I, azoxy ben-
zene and substituted nitroso benzenes? are de-
oxygenated by means of trialkyl phosphite. There
are also reports that ethylene oxides:', phthalic an-
hydride" and pyridine-I oxide' can also be de-
oxygenated employing tert-phosphites. Trialkyl
phosphites are also ·known to deoxygenate non-
steroidal furoxans=".
We thought it worthwhile to study the behav-
iour of triethyl phosphite with steroidal furazan
N-oxides 1,2,3 and 4 which we report in this
paper. The furoxan (1) was prepared by treating
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zole Nsoxide? with acetic anhydride in pyri-
dine at 100°. The compound 1showed IR bands
at 1735, 1655, 1250 and 1035 cm-I and UV
maximum was at 261 nm. In the IH NMR spec-
trum there appeared singlet at <52.03 (3H,
- OCOCH3). Compound 1 was refluxed with
triethyl phosphite under nitrogen atmosphere to
give a dinitrile derivative 5 which showed promi-
nent IR bands at 2240 em-I. Its IH NMR spec-
trum showed singlets at <51.05 and 1.42 for 19-
methyl and 18-methyl, respectively. A singlet ap-
peared at <52.05 for acetoxy function. The a-
configuration of the tertiary nitrile at Carbon-13












The behaviour of triethyl phosphite was further
studied in estrone series. Deoxygenation of furox-
an derivative 29 with triethyl phosphite under the
above mentioned.experimental conditions gave 6.
IR spectrum showed vibrational bands at 2250
and 2228 em - 1 and 1H NMR spectrum exhibited
three-proton singlets at 01.47 (18-CH3) and 3.70
( - OCH3). Similarly refluxing 312 with triethyl
phosphite under nitrogen atmosphere gave 7. It
showed characteristic absorption bands at 2250
cm-I (C=N) in the IR spectrum. 'H NMR
showed peaks at 00.80 (s, 3H, 19-CH3)' 1.53 (s,
3H, 18-CH3) and 2.77 (m, 2H, 15-CH2)'
It is interesting to note the deoxygenation with
triethyl phosphite of furazan N-oxide 413 fused to
six membered ring, which on heating under reflux
under similar conditions with triethyl phosphite
gave a furazan 813. IH NMR spectrum exhibited
singlets at 00.77 (s, 3H, 18-CH3)' 0.82 (s, 3H,
19-CH3) and 2.05 (s, 3H, OCOCH3)13.
These observations lead us to confirm the sug-
gested mechanism for the deoxygenation with
triethyl phosphite under forcing conditions [reflux-
ing with (C2HsO)3P1'4.
It is observed in this study that furazan fused to
another five membered ring D is under strain 14
and there is ring opening giving dinitriles, whereas
furazan fused to six membered ring A of steroid
skeleton has the greater thermodynamic stability
and does not result in the formation of dinitriles.
We made unsuccessful attempts to prepare the
steroidal[16,17-c]-1',2',5'-oxadiazole through this
route from [16,17-c]-1',2',5'-oxadiazole N-oxide or
(6)
(8)
refluxing 16,17 -dioximino- 5-androsten- 3{3-01with
potassium hydroxide and ethylene glycol.
Experimental Section
Melting points reported are uncorrected.
IH NMR spectra (90 MHz) were recorded in
CDCl3 containing TMS as internal reference
(chemical shifts in 0, ppm), IR spectra in KBr
(vmax in em -I) and UV spectra in methanol (Amax
in nm, figures within parentheses refer to log E
values). Mass spectra were recorded on Vg-11-
250J 70S model. Elemental analyses were carried
out on Perkin-Elmer-2400 model.
17{3-Acetoxy-5a-androstano[3, 4-c)-1', 2', 5'-
oxadiazole N-oxide (4). 3,4-Dioximino-5~-
androstan-17 {3-01'S (1g) was dissolved in a mixture
of ethanol (10 mL) and aq. NaOH (20%, 3 mL)
and chilled. Freshly prepared sodium hypochlorite
solution (8 mL) was added to the above chilled
and stirred solution. The reaction mixture was
kept at 0° for 24 hr, poured into ice-cold water,
filtered, washed and dried. The residue so ob-
tained was crystallised from ethanol to yield
17{3-hydroxy-5 a-androstand[3,4-c]-1',2',5'-oxadia-
zole N-oxide (0.65 g, 65.4%), m.p. 208-10°; UV
(MeOH): 261 (3.92); IR: 1635, 1475, 1175,
1075; IH NMR: 0.78 (s, 6H, 18-CH3 and 19-
CH3), 3.67 (t, 1H, 17a-H) (Found: C, 68.40; H,
8.44; N, 8.19. CI9H28N203 requires C, 68.64; H,
8.48; N, 8.42%).
17{3-hydroxy-5 a-androstano[3,4-c]-1 ',2',5' -oxad-
iazole N-oxide (1 g), was dissolved in acetic anhy-
dride (2 mL) and pyridine (5 mL) and heated on
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water bath for 1 hr. After cooling, the reaction
mixture was poured into crushed ice. The preci-
pitate was filtered, washed off free from pyridine
and dried. The product was crystallised from
methanol to yield 4 (0.8 g, 71%), m.p. 221-22°;
UV (MeOH): 261 (3.79); IR: 1725, 1630, 1460,
1240, 1035; IH NMR: 0.78 (s, 3H, 19-CH3)'
0.82 (s, 3H, 18-CH3), 2.05 (s, 3H, - OCOCH3),
4.70 (m, 1H, 17a-H) (Found: C, 67.59; H, 8.30;




l',2',5'-oxadiazole N-oxide (I) (0.5 g) was refluxed
in triethyl phosphite (10 mL) for 15 min under ni-
trogen atmosphere. The reaction mixture was
poured into ice-cold water and made acidic with
dil. H2S04, The precipitated material was filtered,
washed and dried. The product was crystallised
from methanol to yield 5 (0.35 g, 76.6%), m.p.
175-76°; IR: 2240, 2260, 1710, 1360, 1260,
1040, 1030; IH NMR: 1.05 (s, 3H, 19-CH3),
1.42 .(s, 3H, 18.-CH3)' 2.05 (s, 3H, - OCOCH3),
2.72 (d, 2H, 15-CH2), 4.60 (m, IH, 3-CH), 5.40
(m, 1H, 6-CH) (Found: C, 73.68; H, 8.35; N,.
7.78. C21H2SN202requires C, 74.08; H, 8.29; N,
8.23%).
3-Methoxy-16, 17-seco-l, 3, 5(IO)-estratri-
ene-Iti, 17-dinitrile (6). 3-Methoxy-l ,3,5( 10)-es-
tratrieno[16,17-c]-1',2',5'-oxadiazole N-oxide (2)9
(0.3 g) was treated as above to give 6 (0.2 g,
74.1%) m.p. 142-44°; UV: 230 (3.69), 277 (3.28),
285.6 (3.24); IR: 2945, 2250, 2228, 1613, 1574,
1501, 1460, 1432, 1283, 1140, 1045; IH NMR:
1.47 (s, 3H, 18-CH3), 3.70 (s, 3H, -OCH3), 6.60
(s, IH, 4-CH), 6.70 (d, 1H, 2-CH), 7.06 (d, 1H,
l-CH); MS: mlz 294 (M+) (Found: C, 77.21; H,




5a-androstano[3,4-c]furazan (3)12 (0.1 g) was
treated as above to afford 7 (0.055 g, 50%), m.p.
206-0r; UV: 212 (3.65); IR: 2250, 1490, 1425,
1395, 1025, 945; IH NMR: 0.80 (s, 3HJ 19-
CH3), 1.53 (s, 3H, 18-CH3), 2.77 (m, 2H, 15-
CH2) (Found: C, 67.13; H, 6.44; N, 16.24.
C19H24N40.H20 requires C, 66.64; H, 7.65; N,
16.36%).
17~Acetoxy-5ot"androstano [3,4-cj-l',2' ,5' -oxa-
diazole (8). 17P.Acetoxy-5 a-androstano[ 3,4-c]-
l',2',Y-oxadiazole N-oxide (4) (0.2 g) was treated
as above to yield 813(0.11 g, 57.5%), m.p. 177.78°
(lit. 174-76°); UV: 222 (3.61); IR: 1730, 1445,
1390, 1255, 1055, 1040, 875; IH NMR: 0.77 (s,
3H, 18-CH3)' 0.82 (s, 3H, 19-CH3), 2.05 (s, 3H,
- OCOCH3), 4.70 (rn, IH, 17-CH); MS : m/z 358
(M+) (Found: C, 70.52; H, 8.86; N, 7.73.
C21H30N203 requires C, 70.35; H, 8.43; N,
7.82%).
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